The Illinois Biotechnology Industry Organization (iBIO®) and PROPEL today announced the six finalists for the third annual PROPEL Business Plan Competition. In this highly selective competition, formation-stage and early-stage life sciences companies from across Illinois and Wisconsin will compete for a $10,000 cash award during the 2011 iBIO Industry Exposition (iBIO IndEx), February 15 & 16 at the Hyatt Regency Hotel in Chicago.
“This year’s applicants were our strongest and most diverse ever,” said PROPEL Senior Vice President Barbara Goodman. “We are excited to showcase our expanding formation- and early-stage life sciences companies across many technology categories. Their successes to date are due in large part to the active support of our region’s large companies, universities and other members of the life sciences community.”
The six companies will make brief oral presentations and respond to questions from the panel of judges, all of whom are active financial investors. Judges will provide expert feedback to the presenters, enabling them to refine their messages and presentations for future financing and partnering discussions. The 2011 PROPEL Business Plan Competition finalists are:
“The time and efforts of this year’s 10 preliminary-round judges and six finals judges are greatly appreciated and critical to the success of this competition, and to PROPEL overall,” Goodman said.
The theme of this year’s iBIO IndEx, the premier life sciences event in the Midwest, is “Achieving Sustainability.” In addition to the PROPEL Business Plan Competition, other conference highlights that will contribute to this theme include:
For more information on the 2011 iBIO IndEx, including the full conference agenda, breakout session descriptions and speakers, sponsorship packages and registration, visit www.ibio.org/ibioindex.
PROPEL is a series of programs aimed at increasing the number and success rate of life sciences start-up companies in Illinois. PROPEL helps guide the development of formation-stage and early-stage life sciences companies by providing entrepreneurs with access to specialized resources and expertise. PROPEL is supported by the iBIO Institute. To learn more about PROPEL and its programs, visit www.ibiopropel.org.
The Illinois Biotechnology Industry Organization (iBIO) champions biotechnology in Illinois and the surrounding Midwest region. Headquartered in Chicago, iBIO’s mission is to strengthen the leadership position of Illinois and the Midwest as a globally recognized center of medical, agricultural and industrial biotechnology. With leaders from business, academia and government, iBIO promotes the development and retention of new companies as well as corporate expansions. iBIO advocates for sensible public policy at the local, state and federal levels. To learn more about iBIO and its programs, visit www.ibio.org.
iBIO’s Leadership Sponsors are Abbott, Astellas Pharma US, Baxter International Inc. and Takeda Pharmaceuticals North America.Business Wire
Last updated on: 03/02/2011
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.